The Antiangiogenic Quagmire

Is there a future for antiangiogenic therapy with hormone therapy in hormone receptor-positive breast cancer? Dr. Hope Rugo discusses a failed sorafenib trial in the last of 3 video commentaries from the European Multidisciplinary Cancer Congress in Stockholm.

Is there a future for antiangiogenic therapy with hormone therapy in hormone receptor-positive breast cancer? Dr. Hope Rugo discusses a failed sorafenib trial in the last of 3 video commentaries from the European Multidisciplinary Cancer Congress in Stockholm.

Is there a future for antiangiogenic therapy with hormone therapy in hormone receptor-positive breast cancer? Dr. Hope Rugo discusses a failed sorafenib trial in the last of 3 video commentaries from the European Multidisciplinary Cancer Congress in Stockholm.